International Patent: USE OF NUCLEOSIDE ANALOG IN PREPARATION OF DRUG FOR TREATING OR PREVENTING DISEASES CAUSED BY PARAMYXOVIRIDAE VIRUS INFECTIONS

GENEVA, July 31 -- VIGONVITA (SHANGHAI) LIFE SCIENCES CO., LTD. filed a patent application (CN2026/073586) for “USE OF NUCLEOSIDE ANALOG IN PREPARATION OF DRUG FOR TREATING OR PREVENTING DISEASES CAUSED BY PARAMYXOVIRIDAE VIRUS INFECTIONS”. With publication no. WO/2026/158267, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: A61K 31/706

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....